NASDAQ
DiaMedica Therapeutics Inc. (DMAC) has a current ratio of 11.81x as of Tuesday, May 26, 2026. This represents a 35.23% decrease compared to its 12-month average of 18.24x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.